Magnesium for Anxiety: What the Clinical Trials Show

Anxiety disorders affect over 300 million people globally. Interest in magnesium as a nutritional intervention has grown substantially as the mechanistic rationale has become clearer and trial evidence has accumulated. This is now one of the more scientifically grounded areas of supplement research — though it remains considerably less potent than established pharmacological and psychological treatments.

Why Magnesium Might Affect Anxiety

Magnesium is a physiological antagonist of the NMDA receptor, one of the primary excitatory glutamate receptors in the brain. Magnesium blocks the NMDA channel at resting membrane potential, moderating excitatory neurotransmission. This mechanism partially overlaps with the action of ketamine, an NMDA antagonist with established anxiolytic effects. Magnesium also modulates the HPA axis stress response, with deficiency associated with exaggerated cortisol reactions to stressors. Magnesium deficiency affects roughly 48% of Americans based on dietary intake data.

The Clinical Trial Evidence

The 2017 systematic review by Boyle, Lawton and Dye in Nutrients identified 18 studies (8 RCTs and 10 quasi-experimental designs) examining magnesium and subjective anxiety or stress outcomes. Most RCTs reported modest improvements in self-reported anxiety, but the trials were generally small, short (often 6–8 weeks), and in people with mild symptoms or borderline-low magnesium status. The 2017 RCT by Pouteau et al. of 264 mildly stressed adults with low magnesium status showed that 300 mg/day of magnesium (alone, or with vitamin B6) for 8 weeks reduced perceived-stress (DASS-42) scores significantly more than placebo, with the largest effect in participants under the most severe stress. Effects typically appear over 2–6 weeks. Magnesium is not a substitute for evidence-based treatments in moderate-to-severe generalised anxiety disorder or panic disorder.

Practical Guidance

Glycinate, citrate, and threonate forms have the best absorption and CNS-relevant evidence; doses used in anxiety trials range from about 200–400 mg elemental magnesium daily. Loose stools are the main dose-limiting side effect, and the effect is most pronounced with magnesium oxide and citrate.